Carbinoxamine / hydrocodone / phenylephrine Pregnancy and Breastfeeding Warnings
Carbinoxamine / hydrocodone / phenylephrine is also known as: Donatussin MAX, Excof, Excof-SF, Max HC
Carbinoxamine / hydrocodone / phenylephrine Pregnancy Warnings
Carbinoxamine/hydrocodone/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbinoxamine/hydrocodone/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Carbinoxamine / hydrocodone / phenylephrine Breastfeeding Warnings
There are no data on the excretion of carbinoxamine/hydrocodone/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- "Product Information. Excof (carbinoxamine/hydrocodone/phenylephrine)." Stewart-Jackson Pharmaceutical Inc (2005):
References for breastfeeding information
- "Product Information. Excof (carbinoxamine/hydrocodone/phenylephrine)." Stewart-Jackson Pharmaceutical Inc (2005):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.